# Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?

> **NCT00151723** · NA · UNKNOWN · sponsor: **Radboud University Medical Center** · enrollment: 200 (estimated)

## Conditions studied

- Hyperthyroidism

## Interventions

- **PROCEDURE:** treatment with 131I

## Key facts

- **NCT ID:** NCT00151723
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2007-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00151723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00151723, "Does Radioiodine Treatment Prevent Atrial Fibrillation and Bone Loss in Endogenous Subclinical Hyperthyroidism?". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00151723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*